G Medical Innovations Holdings (G Medical Innovations Holdings) EBIT : $-9.86 Mil (TTM As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings EBIT?

G Medical Innovations Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2022 was $-1.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2022 was $-9.86 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. G Medical Innovations Holdings's annualized ROC % for the quarter that ended in Dec. 2022 was -180.06%. G Medical Innovations Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -59.69%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. G Medical Innovations Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -455.61%.

G Medical Innovations Holdings EBIT Historical Data

The historical data trend for G Medical Innovations Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings EBIT Chart

G Medical Innovations Holdings Annual Data

Trend

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

-16.33

-12.52

-11.96

-10.10

-9.86

G Medical Innovations Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
EBIT	Get a 7-Day Free Trial							-7.53	-3.83	-6.27	-8.87	-1.00

Competitive Comparison of G Medical Innovations Holdings's EBIT

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G Medical Innovations Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's EV-to-EBIT falls into.

G Medical Innovations Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-9.86 Mil.

G Medical Innovations Holdings (OTCPK:GMVDF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

G Medical Innovations Holdings's annualized ROC % for the quarter that ended in Dec. 2022 is calculated as:

	ROC % (Q: Dec. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2022 )	+	Invested Capital (Q: Dec. 2022 ))	/ count )
=	-13.242 * ( 1 - -0.45% )	/	( (9.516	+	5.259)	/ 2 )
=	-13.301589	/	7.3875
=	-180.06 %

where

	Invested Capital		(Q: Jun. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.278	-	5.457	-	( 1.509	-	max(0, 10.613	-	5.918	+	1.509	))
=	9.516

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4.825	-	6.686	-	( 0.295	-	max(0, 9.113	-	1.993	+	0.295	))
=	5.259

Note: The Operating Income data used here is two times the semi-annual (Dec. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

G Medical Innovations Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2022		Q: Dec. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.998	/	( ( (4.048 + max(-6.265, 0))	+	(2.647 + max(-5.957, 0)) )	/	2 )
=	-1.998	/	( ( 4.048	+	2.647 )	/	2 )
=	-1.998	/	3.3475
=	-59.69 %

where Working Capital is:

	Working Capital		(Q: Jun. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.566	+	2.338	+	0.171)	-	(5.457	+	0	+	3.883)
=	-6.265

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.593	+	0.292	+	0.462)	-	(6.686	+	0	+	0.618)
=	-5.957

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

G Medical Innovations Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2022 )
	=	-9.864	/	2.165
	=	-455.61 %

G Medical Innovations Holdings EBIT Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Oppenheimer Street, Rehovot, ISR, 7670105

Website

https://www.gmedinnovations.com

G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

Executives

Awm Investment Company, Inc.

10 percent owner

527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022